Compare VIR & NGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIR | NGL |
|---|---|---|
| Founded | 2016 | 1940 |
| Country | United States | United States |
| Employees | N/A | 569 |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2019 | N/A |
| Metric | VIR | NGL |
|---|---|---|
| Price | $8.40 | $12.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $19.63 | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 235.6K |
| Earning Date | 05-06-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,049.62 | N/A |
| P/E Ratio | ★ N/A | $366.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $2.64 |
| 52 Week High | $10.91 | $13.92 |
| Indicator | VIR | NGL |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 50.02 |
| Support Level | $5.14 | $11.04 |
| Resistance Level | $10.29 | $13.00 |
| Average True Range (ATR) | 0.47 | 0.57 |
| MACD | -0.18 | 0.07 |
| Stochastic Oscillator | 3.20 | 33.66 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.